Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. November 2025 13:38 ET | Quelle: PrognomiQ

UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer

PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.
08. Januar 2025 09:00 ET | Quelle: PrognomiQ

PrognomiQ Appoints Joel Kaufman as Chief Financial Officer

PrognomiQ Announces the appointment of Joel Kaufman as Chief Financial Officer, serving on the company's Executive Team.
05. November 2024 09:00 ET | Quelle: PrognomiQ

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform